Table 1.
Severity of hepatic steatosis evaluated by noninvasive radiologic measurements.
Table 2.
Clinical characteristics and laboratory results of perinatally HIV-monoinfected adolescents, stratified by history of serum aminotransferase levels.
Fig 1.
Flow chart of participants through the study.
Abbreviations: CAP, controlled attenuation parameter; MRE, magnetic resonance elastography; MRI, magnetic resonance imaging; NAFLD, nonalcoholic fatty liver disease. a Participants in both groups were matched on age and sex in the ratio 1:1. b Participants were listed as having history of elevated aminotransferase levels if they had AST >50 U/L and/or ALT >30 U/L at least once within the past 12 months. c NAFLD was defined as an evidence of hepatic steatosis (any severity), evaluated by liver ultrasonography. Hepatic fibrosis was defined as significant liver stiffness (≥7.4 kPa), evaluated by transient elastography. d Persistent hepatic abnormalities was defined as an evidence of NAFLD and/or hepatic fibrosis at both initial and one-year follow-up evaluations. e Transient hepatic abnormalities was defined as an evidence of NAFLD and/or hepatic fibrosis at initial evaluation, but having a return-to-normal evaluation by the repeated measurements.
Table 3.
Clinical information of perinatally HIV-monoinfected adolescents with persistent hepatic abnormalities.
Table 4.
Associated factors of persistent hepatic abnormalities among perinatally HIV-monoinfected Asian adolescents.